A Pennsylvania lawmaker took a drug test to prove that having THC in the bloodstream cannot necessarily be equated with being impaired, reported 6abc Action News.
State Rep. Chris Rabb (D), who is behind a push to amend the law that requires proof of impairment for DUI and cannabis, is a medical marijuana patient himself, using CBD tinctures as a sleep aid.
Rabb took a drug test in February, over 12 hours after he consumed a third of a dropper.
"I feel fine to do anything because I'm not impaired," he said. "I wake up feeling bright-eyed and bushy-tailed with no symptoms."
After witnessing a murder in 2016, Rabb was diagnosed with post-traumatic stress disorder (PTSD), which led him to seek a medical marijuana card.
Considering that Pennsylvania and neighboring Delaware have enacted zero-tolerance laws, those who use medical marijuana risk severe consequences if caught driving with traces of cannabis in their system.
Under the current state law, over 700,000 medical marijuana patients face arrest, prosecution and conviction for consuming their medicine while operating a motor vehicle.
While opponents of efforts such as Rabb's stress that marijuana and driving are a dangerous combination, the drug test results only proved the lawmaker's point.
"Said I was full of cannabis," Rabbs said. "And I've been told I am full of a lot of things (laughs), but I never saw a test that said I had cannabis."
Meanwhile, in June, a measure to protect Pennsylvania medical marijuana users from being charged with driving under the influence was unanimously approved by the Senate Transportation Committee.
The legislation from Sen. Camera Bartolotta sought to make medical cannabis equal to any other prescription narcotic, requiring proof of impairment of the person's ability to drive in order to be charged with DUI.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!